Shaun L Greene
Dados Biográficos
| ID | 5548744 |
|---|---|
| NOME | Shaun L Greene |
| PRENOMES | Shaun L |
| SOBRENOME | Greene |
| ASSINATURA | GREENE S L |
| AFILIAÇÕES | The University of Melbourne |
| ORCID | 0000-0002-7423-2467 |
| VERIFICADO | Sim |
| TOTAL DE OBRAS | 8 |
| TOTAL DE CITAÇÕES | 0 |
| TOTAL COMO AUTOR | 8 |
| TOTAL COMO EDITOR | 0 |
| PRIMEIRO ANO DE PUBLICAÇÃO | 2023 |
| ANO MAIS RECENTE DE PUBLICAÇÃO | 2026 |
| ÍNDICE H | 0 |
Accuracy of Patient‐Reported Exposure to New Psychoactive Substances and Other Illicit Drugs in Australian Emergency Departments
Clinical toxicity of nitazene detections in two Australian emergency department toxicosurveillance systems
Novel benzodiazepines in illicit drug use
BACKGROUND: Novel or unregulated benzodiazepines are increasingly detected in illicit drug markets and may be perceived to pose greater clinical risk than regulated pharmaceutical benzodiazepines. However, much of the evidence underpinning these concerns derives from case reports, surveillance data, and settings characterised by extensive polysubstance exposure. We examined whether detection of novel/unregulated benzodiazepines is associated with…
Novel psychoactive substances in Australian emergency departments
Drug intelligence data generated in an acute harm setting such as the ED can provide early warning of drugs of concern circulating in the community, including NPS. This facilitates rapid community responses to reduce harm and inform subsequent public health responses
A multicentre case series of analytically confirmed gamma‐hydroxybutyrate intoxications in Western Australian emergency departments
Novel harm reduction measures at music festivals in Australia
Characteristics and time course of benzodiazepine-type new psychoactive substance detections in Australia
A risk-based approach to community illicit drug toxicosurveillance
Sem obras proeminentes nesta página.
Characteristics and time course of benzodiazepine-type new psychoactive substance detections in Australia
A risk-based approach to community illicit drug toxicosurveillance
A multicentre case series of analytically confirmed gamma‐hydroxybutyrate intoxications in Western Australian emergency departments
Novel harm reduction measures at music festivals in Australia
Novel psychoactive substances in Australian emergency departments
Drug intelligence data generated in an acute harm setting such as the ED can provide early warning of drugs of concern circulating in the community, including NPS. This facilitates rapid community responses to reduce harm and inform subsequent public health responses
Accuracy of Patient‐Reported Exposure to New Psychoactive Substances and Other Illicit Drugs in Australian Emergency Departments
Clinical toxicity of nitazene detections in two Australian emergency department toxicosurveillance systems
Novel benzodiazepines in illicit drug use
BACKGROUND: Novel or unregulated benzodiazepines are increasingly detected in illicit drug markets and may be perceived to pose greater clinical risk than regulated pharmaceutical benzodiazepines. However, much of the evidence underpinning these concerns derives from case reports, surveillance data, and settings characterised by extensive polysubstance exposure. We examined whether detection of novel/unregulated benzodiazepines is associated with…
Forensic Toxicology and Drug Analysis (8 obras) · Medicine (6 obras) · Medical emergency (4 obras) · Opioid Use Disorder Treatment (4 obras) · Psychiatry (4 obras) · Public health (4 obras) · Drug (3 obras) · Emergency department (3 obras) · Harm reduction (3 obras) · Internal Medicine (3 obras)